JUMP — Leveljump Healthcare Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
Annual income statement for Leveljump Healthcare, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.37 | 5.46 | 6.72 | 9.23 | 12.6 |
Cost of Revenue | |||||
Gross Profit | 1.04 | 1.04 | 1.35 | 1.57 | 2.36 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.09 | 14.2 | 8.95 | 8.99 | 13.4 |
Operating Profit | 0.286 | -8.78 | -2.23 | 0.238 | -0.823 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.106 | -11.6 | -2.23 | 0.185 | -2.21 |
Net Income After Taxes | 0.106 | -11.6 | -2.23 | 0.185 | -2.21 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.106 | -11.6 | -2.23 | 0.185 | -2.21 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.106 | -11.6 | -2.23 | 0.185 | -2.21 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.005 | -0.07 | -0.046 | -0.011 | -0.024 |